Cargando…
Legomedicine—A Versatile Chemo-Enzymatic Approach for the Preparation of Targeted Dual-Labeled Llama Antibody–Nanoparticle Conjugates
[Image: see text] Conjugation of llama single domain antibody fragments (Variable Heavy chain domains of Heavy chain antibodies, VHHs) to diagnostic or therapeutic nanoparticles, peptides, proteins, or drugs offers many opportunities for optimized targeted cancer treatment. Currently, mostly nonspec...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical
Society
2017
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5330650/ https://www.ncbi.nlm.nih.gov/pubmed/28045502 http://dx.doi.org/10.1021/acs.bioconjchem.6b00638 |
_version_ | 1782511261025566720 |
---|---|
author | van Lith, Sanne A. M. van Duijnhoven, Sander M. J. Navis, Anna C. Leenders, William P. J. Dolk, Edward Wennink, Jos W. H. van Nostrum, Cornelus F. van Hest, Jan C. M. |
author_facet | van Lith, Sanne A. M. van Duijnhoven, Sander M. J. Navis, Anna C. Leenders, William P. J. Dolk, Edward Wennink, Jos W. H. van Nostrum, Cornelus F. van Hest, Jan C. M. |
author_sort | van Lith, Sanne A. M. |
collection | PubMed |
description | [Image: see text] Conjugation of llama single domain antibody fragments (Variable Heavy chain domains of Heavy chain antibodies, VHHs) to diagnostic or therapeutic nanoparticles, peptides, proteins, or drugs offers many opportunities for optimized targeted cancer treatment. Currently, mostly nonspecific conjugation strategies or genetic fusions are used that may compromise VHH functionality. In this paper we present a versatile modular approach for bioorthogonal VHH modification and conjugation. First, sortase A mediated transPEGylation is used for introduction of a chemical click moiety. The resulting clickable VHHs are then used for conjugation to other groups employing the Cu(+)-independent strain-promoted alkyne–azide cycloadition (SPAAC) reaction. Using this approach, tail-to-tail bispecific VHHs and VHH-targeted nanoparticles are generated without affecting VHH functionality. Furthermore, this approach allows the bioconjugation of multiple moieties to VHHs for simple and convenient production of VHH-based theranostics. |
format | Online Article Text |
id | pubmed-5330650 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | American Chemical
Society |
record_format | MEDLINE/PubMed |
spelling | pubmed-53306502017-03-02 Legomedicine—A Versatile Chemo-Enzymatic Approach for the Preparation of Targeted Dual-Labeled Llama Antibody–Nanoparticle Conjugates van Lith, Sanne A. M. van Duijnhoven, Sander M. J. Navis, Anna C. Leenders, William P. J. Dolk, Edward Wennink, Jos W. H. van Nostrum, Cornelus F. van Hest, Jan C. M. Bioconjug Chem [Image: see text] Conjugation of llama single domain antibody fragments (Variable Heavy chain domains of Heavy chain antibodies, VHHs) to diagnostic or therapeutic nanoparticles, peptides, proteins, or drugs offers many opportunities for optimized targeted cancer treatment. Currently, mostly nonspecific conjugation strategies or genetic fusions are used that may compromise VHH functionality. In this paper we present a versatile modular approach for bioorthogonal VHH modification and conjugation. First, sortase A mediated transPEGylation is used for introduction of a chemical click moiety. The resulting clickable VHHs are then used for conjugation to other groups employing the Cu(+)-independent strain-promoted alkyne–azide cycloadition (SPAAC) reaction. Using this approach, tail-to-tail bispecific VHHs and VHH-targeted nanoparticles are generated without affecting VHH functionality. Furthermore, this approach allows the bioconjugation of multiple moieties to VHHs for simple and convenient production of VHH-based theranostics. American Chemical Society 2017-01-03 2017-02-15 /pmc/articles/PMC5330650/ /pubmed/28045502 http://dx.doi.org/10.1021/acs.bioconjchem.6b00638 Text en Copyright © 2017 American Chemical Society This is an open access article published under a Creative Commons Non-Commercial No Derivative Works (CC-BY-NC-ND) Attribution License (http://pubs.acs.org/page/policy/authorchoice_ccbyncnd_termsofuse.html) , which permits copying and redistribution of the article, and creation of adaptations, all for non-commercial purposes. |
spellingShingle | van Lith, Sanne A. M. van Duijnhoven, Sander M. J. Navis, Anna C. Leenders, William P. J. Dolk, Edward Wennink, Jos W. H. van Nostrum, Cornelus F. van Hest, Jan C. M. Legomedicine—A Versatile Chemo-Enzymatic Approach for the Preparation of Targeted Dual-Labeled Llama Antibody–Nanoparticle Conjugates |
title | Legomedicine—A Versatile Chemo-Enzymatic Approach
for the Preparation of Targeted Dual-Labeled Llama Antibody–Nanoparticle
Conjugates |
title_full | Legomedicine—A Versatile Chemo-Enzymatic Approach
for the Preparation of Targeted Dual-Labeled Llama Antibody–Nanoparticle
Conjugates |
title_fullStr | Legomedicine—A Versatile Chemo-Enzymatic Approach
for the Preparation of Targeted Dual-Labeled Llama Antibody–Nanoparticle
Conjugates |
title_full_unstemmed | Legomedicine—A Versatile Chemo-Enzymatic Approach
for the Preparation of Targeted Dual-Labeled Llama Antibody–Nanoparticle
Conjugates |
title_short | Legomedicine—A Versatile Chemo-Enzymatic Approach
for the Preparation of Targeted Dual-Labeled Llama Antibody–Nanoparticle
Conjugates |
title_sort | legomedicine—a versatile chemo-enzymatic approach
for the preparation of targeted dual-labeled llama antibody–nanoparticle
conjugates |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5330650/ https://www.ncbi.nlm.nih.gov/pubmed/28045502 http://dx.doi.org/10.1021/acs.bioconjchem.6b00638 |
work_keys_str_mv | AT vanlithsanneam legomedicineaversatilechemoenzymaticapproachforthepreparationoftargetedduallabeledllamaantibodynanoparticleconjugates AT vanduijnhovensandermj legomedicineaversatilechemoenzymaticapproachforthepreparationoftargetedduallabeledllamaantibodynanoparticleconjugates AT navisannac legomedicineaversatilechemoenzymaticapproachforthepreparationoftargetedduallabeledllamaantibodynanoparticleconjugates AT leenderswilliampj legomedicineaversatilechemoenzymaticapproachforthepreparationoftargetedduallabeledllamaantibodynanoparticleconjugates AT dolkedward legomedicineaversatilechemoenzymaticapproachforthepreparationoftargetedduallabeledllamaantibodynanoparticleconjugates AT wenninkjoswh legomedicineaversatilechemoenzymaticapproachforthepreparationoftargetedduallabeledllamaantibodynanoparticleconjugates AT vannostrumcornelusf legomedicineaversatilechemoenzymaticapproachforthepreparationoftargetedduallabeledllamaantibodynanoparticleconjugates AT vanhestjancm legomedicineaversatilechemoenzymaticapproachforthepreparationoftargetedduallabeledllamaantibodynanoparticleconjugates |